Learn About Multisystem Inflammatory Syndrome in Children

What is the definition of Multisystem Inflammatory Syndrome in Children?
Multisystem inflammatory syndrome in children (MIS-C) is a rare syndrome that appears to be linked to COVID-19 infection, in which different body organs become severely inflamed, such as the skin, eyes, brain, gastrointestinal system, heart, lungs, and kidneys.
Save information for later
Sign Up
What are the symptoms of Multisystem Inflammatory Syndrome in Children?
Symptoms of multisystem inflammatory syndrome in children can vary and require emergency treatment to prevent permanent organ damage. Symptoms may include fatigue, fever of 100.4° lasting 24 hours or longer, bloodshot eyes (conjunctivitis), rash, red, cracked lips, vomiting, diarrhea, severe abdominal pain, neck pain, difficulty breathing (dyspnea) or rapid breathing, cough, sore throat, chest pain or pressure, dizziness, confusion, loss of consciousness, bluish lips or face, low blood pressure, heart inflammation (myocarditis), rapid heartbeat, redness or swelling of lips, tongue (with red bumps), hands, or feet, and enlarged lymph nodes.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Multisystem Inflammatory Syndrome in Children?
While treatment for children with multisystem inflammatory syndrome depends on the organs that are affected and the severity of the symptoms, children with this syndrome will usually need to be treated in the hospital by a multidisciplinary team with both supportive care (blood pressure medications, fluids, and oxygen to alleviate symptoms) and drugs to treat inflammation, such as antibiotics, steroid therapy, intravenous immunoglobulin (IVIG), and cytokine targeted therapies. Some children with this syndrome may need to be treated in the pediatric intensive care unit with ventilators, anticoagulants, and, in rare cases, extracorporeal membrane oxygenation.
Who are the top Multisystem Inflammatory Syndrome in Children Local Doctors?
Distinguished
Highly rated in
10
conditions

CUIMC/NewYork-Presbyterian Morgan Stanley Children's Hospital

New York, NY 

Mercedes Martinez is in New York, New York. Dr. Martinez has been practicing medicine for over 34 years and is rated as a Distinguished doctor by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children. She is also highly rated in 10 other conditions, according to our data. Her top areas of expertise are Autoimmune Hepatitis, Sclerosing Cholangitis, Cholangitis, and Liver Transplant. She is licensed to treat patients in New York. Dr. Martinez is currently accepting new patients.

Distinguished
Highly rated in
5
conditions
Pediatric Hematology Oncology

Children's Hospital Of Philadelphia

Philadelphia, PA 

Caroline Diorio is a Pediatric Hematologist Oncology doctor in Philadelphia, Pennsylvania. Dr. Diorio is rated as a Distinguished doctor by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children. She is also highly rated in 5 other conditions, according to our data. Her top areas of expertise are Multisystem Inflammatory Syndrome in Children, Breast Cancer, Infantile Neutropenia, and Severe Acute Respiratory Syndrome. She is licensed to treat patients in Pennsylvania.

 
 
 
 
Learn about our expert tiers
Learn more
Distinguished
Highly rated in
5
conditions
Pediatric Pulmonology

MGH Children's Specialties At Southern New Hampshire Med Ctr

Nashua, NH 

Lael Yonker is a Pediatric Pulmonologist in Nashua, New Hampshire. Dr. Yonker has been practicing medicine for over 15 years and is rated as a Distinguished doctor by MediFind in the treatment of Multisystem Inflammatory Syndrome in Children. She is also highly rated in 5 other conditions, according to our data. Her top areas of expertise are Multisystem Inflammatory Syndrome in Children, COVID-19, Severe Acute Respiratory Syndrome, and Cystic Fibrosis. She is licensed to treat patients in Massachusetts. Dr. Yonker is currently accepting new patients.

What are the latest Multisystem Inflammatory Syndrome in Children Clinical Trials?
A Phase 2a (Proof of Concept), Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AT1001 for the Treatment of COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C)
Match to trials
Find the right clinical trials for you in under a minute
Get started
Long COVID Kids DK - Investigating Long-term Hospitalizations, GP Visits, Co-morbidities, Drug Prescriptions and Symptoms in Danish Children With Covid-19
What are the Latest Advances for Multisystem Inflammatory Syndrome in Children?
Multisystem inflammatory syndrome in children: a cross-sectional study of cases and factors associated with deaths during the COVID-19 pandemic in Brazil, 2020.
Multisystem Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Role of Oxidative Stress.
Tired of the same old research?
Check Latest Advances
Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.